ConcertAI
Latest round
- Series C
Last raised
- Mar 2022
Total raised
- $300M
Investors
- 5
About ConcertAI
Founded in 2018 and based in Massachusetts, US, ConcertAI LLC operates as an AI-powered SaaS data company that develops medical research tools for oncology research and data analytics. The CEO of the company is Eron Kelly.9 billion post-money. ConcertAI LLC develops STAR, an enterprise solution for patient insights, and SPRINT, a cloud-based solution for contracting. The company's products include RWD360™, which is a repository of pan tumor clinical data; Patient360™ to identify base rates of clinical characteristics, disease severity measures, and treatment outcomes; and Genome360™ to identify patients by a variant in a given gene, such as mutation, amplification, rearrangement, etc. The company also evaluates the clinical trial efficiency research using custom patient surveys to help pharmaceutical companies evaluate currently approved treatments and also develop new treatments for cancer of bladder, breast, liver, lung, etc.
Who invested in ConcertAI
5 investors across 2 rounds
See all investors in ConcertAI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ConcertAI
Who invested in ConcertAI?
ConcertAI has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ConcertAI raised?
ConcertAI has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ConcertAI last raise money?
ConcertAI's most recent round on record is a Series C, in Mar 2022.
What does ConcertAI do?
Founded in 2018 and based in Massachusetts, US, ConcertAI LLC operates as an AI-powered SaaS data company that develops medical research tools for oncology research and data analytics.
Where is ConcertAI headquartered?
ConcertAI is headquartered in Cambridge, US.
Which VCs invest in companies like ConcertAI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at ConcertAI's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like ConcertAI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.